AccessibilityHelpAbout Us
Smith & Nephew Plc logo

Smith & Nephew Plc(NYSE) SNN

Market Cap$11.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)+435%
5 Year-15%
1 Year-24%
1 Month-6%
$27.56
-0.79%
-0.22Today
After hours$27.58+$0.02 (+0.07%)
Smith & Nephew Plc last closing stock price
MetricPriceDate
Last closeUSD 27.562026-09-18
Smith & Nephew Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.22%USD 27.502026-09-11
1 month-5.97%USD 29.312026-08-19
3 month-8.38%USD 30.082026-06-18
Year to date-14.73%USD 32.322025-12-31
1 year-23.82%USD 36.182025-09-18
3 year+15.35%USD 23.892023-09-19
5 year-14.61%USD 32.282021-09-17
Since inception+434.61%USD 5.161999-11-16

Smith & Nephew Plc Financials at a Glance

Market Cap

$11.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.24B

Net Income (TTM)

$1.13B

EPS (TTM)

$1.47

P/E Ratio

18.61

Dividend

$0.78

Beta (Volatility)

0.65 (Low)

Price

$27.56

Volume

1,452,747.5

Open

$27.55

Previous Close

$27.56

Daily Range

$27.43 - $27.66

52-Week Range

$27.23 - $37.51

Estimated Earnings Date

Feb 23, 2027

SNN News

Copy of senior man talking to doctor holding clipboard medical expenses healthcare hospital

3 Cheap Surgical Stocks to Buy Now Before They Bounce Back

James HalleyJul 9, 2020
GettyImages-1000656954

Can Medical Device Stocks Help Rebuild Your Portfolio?

David HaenMar 24, 2020
Getty Images Artificial Joint Total Knee Replacement

Why Shares of Smith & Nephew Fell 10.2% in October

John BromelsNov 12, 2019
GettyImages-511535378

Here's Why NuVasive Stock Is Soaring Today

Brian FeroldiFeb 11, 2019
MNKD inhalers

Why MannKind, Nutanix, and Smith & Nephew Jumped Today

Dan CaplingerOct 10, 2017
Dividends graphic

3 Best Dividend Stocks in the Medical Device Industry

Keith SpeightsJun 3, 2017
.Daily fool

Intel Staves Off the Dow's Drop

Dan CarrollJun 24, 2014
7650804342_5778937d0a_o

The 3 Best Tax Havens for Health Care Companies

Sean WilliamsJun 21, 2014
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Smith & Nephew plc is a global medical technology company that develops, manufactures, and sells medical devices and services. The company operates in three main segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, serving healthcare providers worldwide.

Products and Services
  • Knee and hip implants for joint replacement and revision procedures
  • Sports medicine products for minimally invasive surgeries and soft tissue repair
  • Advanced wound care solutions for chronic and acute wounds
Growth Outlook
  • Revenue of $3.1 billion in Q2 2026, indicating strong market demand
  • Consistent gross profit margin around 70%, reflecting operational efficiency
  • Positive cash flow from operations, supporting future investments and growth
Financial Highlights
  • Net income of $303 million in Q2 2026, showcasing profitability
  • Trailing twelve-month (TTM) P/E ratio of 18.17, indicating reasonable valuation
  • Dividend yield of 2.8%, providing attractive returns to shareholders
Smith & Nephew plc has established itself as a leader in the medical devices industry, with a diverse product portfolio that addresses various healthcare needs. The company's focus on innovation and quality has positioned it well for future growth, as evidenced by its strong revenue performance and profitability metrics. The consistent gross profit margin and positive cash flow from operations further highlight the company's operational efficiency and financial health. With a solid dividend yield, Smith & Nephew offers potential investors an opportunity to benefit from both capital appreciation and income generation.
AI Generated • Sep 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

18,362

CEO

Deepak S Nath, PhD

Website

www.smith-nephew.com

Headquarters

Watford, HRT WD18 8YE, GB

SNN Financials

Key Financial Metrics (TTM)

Gross Margin

68.18%

Operating Margin

16.69%

Net Income Margin

10.08%

Return on Equity

12.25%

Return on Capital

9.22%

Return on Assets

5.81%

Earnings Yield

5.37%

Dividend Yield

2.84%

Payout Ratio

52.32%

Stock Overview

Market Cap

$11.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

418.51M

Volume

1.45M

Avg. Volume

1.71M

Financials (TTM)

Gross Profit

$8.51B

Operating Income

$1.57B

EBITDA

$2.82B

Operating Cash Flow

$2.48B

Capital Expenditure

-$832.00M

Free Cash Flow

$1.65B

Cash & ST Invst.

$754.00M

Total Debt

$3.79B

Smith & Nephew Plc Performance Analysis

Smith & Nephew Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 5,211,781,6180.0%
20232023-12-31USD 5,570,508,3216.9%
20242024-12-31USD 5,812,444,7834.3%
20252025-12-31USD 6,178,404,4716.3%
Smith & Nephew Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-315.5%
Q22025-06-30-0.7%
Q42025-12-318.2%
Q22026-06-27-3.3%
Smith & Nephew Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.51-57.2%
20232023-12-31USD 0.6018.5%
20242024-12-31USD 0.9455.6%
20252025-12-31USD 1.4452.5%
Smith & Nephew Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-8.0%
Q22025-06-3047.8%
Q42025-12-3111.8%
Q22026-06-27-7.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.10B

+9.6%

Gross Profit

$2.20B

+11.2%

Gross Margin

70.91%

N/A

Market Cap

$11.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$628.15K

N/A

Employees

18,362

N/A

Net Income

$303.00M

+41.6%

EBITDA

$748.00M

+24.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$754.00M

+32.7%

Total Debt

$3.79B

+3.6%

Accounts Receivable

$1.49B

+9.7%

Inventory

$2.11B

-15.2%

Long Term Debt

$3.21B

-1.9%

Short Term Debt

$573.00M

+50.8%

Return on Assets

5.81%

N/A

Return on Invested Capital

11.81%

N/A

Free Cash Flow

$260.00M

+293.9%

Operating Cash Flow

$450.00M

+89.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FMSFresenius Medical Care AG & Co. KGaA
$22.20+0.59%
COOThe Cooper Companies, Inc.
$55.29+2.82%
TEMTempus AI, Inc.
$77.84-3.14%
NBIXNeurocrine Biosciences, Inc.
$146.23-3.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$152.71-1.36%
NVDANvidia
$222.27+1.34%
AGNCAGNC Investment Corp.
$9.87-0.40%
INTCIntel
$108.60-0.18%

Questions About SNN

What is the current price of Smith & Nephew Plc?

Smith & Nephew Plc is trading at $27.56 per share.

What is the 52-week range for Smith & Nephew Plc?

Over the past 52 weeks, Smith & Nephew Plc has traded between $27.23 and $37.51.

How much debt does Smith & Nephew Plc have?

As of the most recent reporting period, Smith & Nephew Plc reported total debt of $3.33B.

How much cash does Smith & Nephew Plc have on hand?

Smith & Nephew Plc reported $557.00M in cash and cash equivalents in its most recent financial results.

What is Smith & Nephew Plc’s dividend yield?

Smith & Nephew Plc currently has a dividend yield of 2.84%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services